Filing Flows › Lifecore Biomedical (LFCR) › Q1 FY26
Lifecore Biomedical (LFCR) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Nov 6, 2025
Lifecore Biomedical (LFCR) reported revenue of $31.1M for the first quarter fiscal 2026 (Q1 FY26). Operating margin was -9.9%, net loss $10.0M (32.1% of revenue).
Lifecore Biomedical, Q1 FY26: revenue $31.1M, operating margin -9.9%, net loss $10.0M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.1M | — | — |
| Operating profit | −$3.1M | -158% | — |
| Net earnings | −$10.0M | — | — |
| Operating cash flow | $1.8M | — | — |
| Free cash flow | $25K | — | — |
What changed
Revenue was $31.1M in Q1 FY26. CDMO was the largest line at 70% of revenue.
Gross margin was 25.0%. Operating costs exceeded revenue by $3.1M, an operating margin of -9.9%. The quarter ended with a net loss of $10.0M. Net interest and other expense of $6.6M was the main reason.
Operating cash flow was $1.8M. Non-cash charges added back $2.0M of depreciation and $2.4M of share-based compensation. Working capital and other items added $7.4M. Capital expenditures of $1.7M left free cash flow of $25K.
Questions
What was Lifecore Biomedical's revenue in the first quarter fiscal 2026?
Lifecore Biomedical (LFCR) reported revenue of $31.1M for the first quarter fiscal 2026 (Q1 FY26).
Was Lifecore Biomedical profitable in the first quarter fiscal 2026?
Operating loss was $3.1M (-9.9% of revenue) and net loss $10.0M.